ArticleEye (London, England)2025

From pro-re-nata to fixed-interval regimen: evolving real-world treatment paradigms in anti-VEGF therapy for neovascular AMD.

Daniele Veritti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.